Donepezil
Donepezil is a cholinesterase inhibitor used to manage symptoms of Alzheimer’s disease, including mild, moderate, and severe stages, depending on the product’s approval. It works by inhibiting acetylcholinesterase, an enzyme responsible for breaking down acetylcholine, thereby increasing the availability of this neurotransmitter involved in memory and cognitive function. Donepezil is commonly available as oral tablets, orally disintegrating tablets, and other formulations depending on the market. Common side effects include nausea, diarrhoea, vomiting, loss of appetite, insomnia, and muscle cramps. It may also cause a slow heart rate or fainting in susceptible individuals. Donepezil can help manage symptoms but does not cure Alzheimer’s disease or stop its underlying progression.
Donepezil was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Donepezil, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Donepezil from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Donepezil, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
